The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment.
about
Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.Eyeblink Conditioning and Novel Object Recognition in the Rabbit: Behavioral Paradigms for Assaying Psychiatric DiseasesUpdate on the development of lurasidone as a treatment for patients with acute schizophreniaIntra-accumbens injection of a dopamine aptamer abates MK-801-induced cognitive dysfunction in a model of schizophreniaPrenatal nicotine changes the response to postnatal chlorpyrifos: Interactions targeting serotonergic synaptic function and cognitionDopaminergic and serotonergic drug use: a nationwide register-based study of over 1,300,000 older peopleThe effects of ketamine and risperidone on eye movement control in healthy volunteers.Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice.NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.Prevention of the phencyclidine-induced impairment in novel object recognition in female rats by co-administration of lurasidone or tandospirone, a 5-HT(1A) partial agonist.Subanesthetic ketamine treatment promotes abnormal interactions between neural subsystems and alters the properties of functional brain networks.Effect of clozapine on ketamine-induced deficits in attentional set shift task in miceComparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.Kefir protective effects against nicotine cessation-induced anxiety and cognition impairments in ratsMK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia.Synthesis and evaluation of dimeric derivatives of 5-HT(2A) receptor (5-HT(2A)R) antagonist M-100907.The novel antipsychotic drug lurasidone enhances N-methyl-D-aspartate receptor-mediated synaptic responses.Hippocampal serotonin depletion unmasks differences in the hyperlocomotor effects of phencyclidine and MK-801: quantitative versus qualitative analysesInvolvement of GABAB Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4 Receptor, LSP4-2022.Disrupting the clustering of GABAA receptor α2 subunits in the frontal cortex leads to reduced γ-power and cognitive deficits.Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis.The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?Selective serotonergic excitation of callosal projection neurons.Ketamine induces a robust whole-brain connectivity pattern that can be differentially modulated by drugs of different mechanism and clinical profileQuetiapine and Buspirone Both Elevate Cortical Levels of Noradrenaline and Dopamine In vivo, but Do Not have Synergistic Effects.Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age.The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats.Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats.Repeated aripiprazole treatment causes dopamine D2 receptor up-regulation and dopamine supersensitivity in young rats.Subchronic treatment with phencyclidine in adolescence leads to impaired exploratory behavior in adult rats without altering social interaction or N-methyl-D-aspartate receptor binding levels.Comparison of the MK-801-induced increase in non-rewarded appetitive responding with dopamine agonists and locomotor activity in rats.Serotonin (5-HT)1A receptor agonism and 5-HT7 receptor antagonism ameliorate the subchronic phencyclidine-induced deficit in executive functioning in mice.Loudness- and time-dependence of auditory evoked potentials is blunted by the NMDA channel blocker MK-801.The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats.CB2 receptor agonism reverses MK-801-induced disruptions of prepulse inhibition in mice.
P2860
Q24595389-16394B44-3448-46F2-91DA-082BA026739CQ26779267-411206C5-0A06-4739-A8E1-A8D104DBD359Q27009585-912ECE77-6795-4FA9-A2C0-CAFCF9801255Q27332082-2D4093A4-C176-43DC-AFCE-F019221964EAQ28387670-590C5DFC-6AD4-43F5-B396-ADCACAA3F87DQ28476572-2043429D-C080-49D0-9A19-036E36D68EC4Q30437913-686DA2AA-68E1-40E7-AE5C-1CC6AEDEB55BQ30439246-6EEDE4DE-BBBC-4BCB-8FFF-7A014C4E5E64Q30465008-8B2225F6-F27A-4A38-8347-21B3E304BF47Q30524240-FB088666-8C34-4C9C-9E83-CCCD50B9363BQ33620630-91A46244-2378-4C6B-9ED7-8E8E0F86A699Q33841881-42D31F1A-C2F6-4610-9054-A053428C1941Q34169978-CF99455C-9E8F-432D-A4A8-778878A2879AQ34653803-78C8369A-B8C2-4B59-B362-A391809B6C48Q34813538-50E8AB72-447A-45A8-80AC-E2194F9AB42FQ35598966-4C262220-A96A-42A2-9474-7BCB8D979FA3Q35661784-BB770D96-5B67-4D1D-A450-34C1FF33B0FCQ35688500-9A6A12E7-8844-4DA1-8D6E-B0E10937A4E4Q37129398-481F83D1-0B1C-4902-82C7-6B0EC6366A04Q37172877-D226D836-D192-4FA8-B17E-B0E430936AE9Q37236602-213AB5C5-EABE-49A6-868E-88FF762B273DQ38149953-B7E9F9B2-BFAA-45FD-9513-41FC1C0FD1EAQ38258215-B144269B-D8A0-454A-80AC-6BBBC93797F0Q38592139-B5CF0C68-097F-43A1-BB14-5F7F816001B7Q41813841-CD321C35-2066-4719-B175-B1F85C5CE094Q42009185-0750BF79-A490-4A61-B23E-F014307C69D8Q42325246-D13BDD31-F123-4F5C-9057-7262CAE0A4BCQ43894817-BD25ABA4-FBE9-4B55-955B-A722E7230759Q44655683-E3DC399F-43CC-4D27-9815-BC152848BFB9Q45052012-E5B6BAE4-FDC9-4ED4-AFB6-B6D2EE6B2FEAQ45377706-87E4FE60-581D-4B41-840B-DDEB5C211B4BQ47756680-D413CFF1-21C6-4C42-B3B1-62AF9FD5077FQ47999342-287A70E7-C4FD-4CBD-ACCE-9D0669305AE4Q50550002-01421823-EA15-4DC8-941A-F277B3B9C0D8Q50566405-35FC2E76-8D1E-4CFE-B993-0E16D2C115C4Q50974329-3E887333-7AE8-4551-81A9-14366105804EQ52649152-8DD8677A-AB88-4308-A0BA-D7798DCF2044
P2860
The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of serotonin in the N ...... osis and cognitive impairment.
@en
The role of serotonin in the N ...... osis and cognitive impairment.
@nl
type
label
The role of serotonin in the N ...... osis and cognitive impairment.
@en
The role of serotonin in the N ...... osis and cognitive impairment.
@nl
prefLabel
The role of serotonin in the N ...... osis and cognitive impairment.
@en
The role of serotonin in the N ...... osis and cognitive impairment.
@nl
P2093
P2860
P1433
P1476
The role of serotonin in the N ...... osis and cognitive impairment.
@en
P2093
Bill W Massey
Herbert Y Meltzer
Masakuni Horiguchi
P2860
P2888
P304
P356
10.1007/S00213-010-2137-8
P577
2011-01-08T00:00:00Z